Vanda Pharmaceuticals
VNDA
#8239
Rank
โ‚น30.07 B
Marketcap
โ‚น500.14
Share price
-3.36%
Change (1 day)
22.04%
Change (1 year)

Revenue for Vanda Pharmaceuticals (VNDA)

Revenue in 2026 (TTM): โ‚น19.47 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น21.02 Billion. In 2025 the company made a revenue of โ‚น19.39 Billion an increase over the revenue in the year 2024 that were of โ‚น17.05 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Vanda Pharmaceuticals from 2009 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น19.47 B0.4%
2025 โ‚น19.39 B13.77%
2024 โ‚น17.05 B6.33%
2023 โ‚น16.03 B-23.81%
2022 โ‚น21.05 B5.26%
2021 โ‚น19.99 B10.19%
2020 โ‚น18.14 B12.03%
2019 โ‚น16.20 B19.98%
2018 โ‚น13.50 B28.11%
2017 โ‚น10.54 B6.23%
2016 โ‚น9.92 B35.83%
2015 โ‚น7.30 B129.81%
2014 โ‚น3.17 B51.87%
2013 โ‚น2.09 B16.81%
2012 โ‚น1.79 B8.33%
2011 โ‚น1.65 B3.38%
2010 โ‚น1.60 B658.3%
2009 โ‚น0.21 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚น9.303 T 44,147.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น5.462 T 25,879.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น6.113 T 28,972.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น6.975 T 33,075.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น6.350 T 30,099.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.681 T 22,162.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA